FAQs

FAQs

Who does Vasantis work with?

Vasantis works exclusively with pharmaceutical companies in the UK.

What is the remote monitoring platform used by Vasantis?

Vasantis uses the Clinitouch platform which is in use in the UK by the NHS.

Can I work directly with Clinitouch?

No. Vasantis is Clinitouch’s technology partner for the pharmaceutical industry.

What therapeutic area is suitable?

Ideal for chronic conditions such as COPD, heart failure, Parkinsons, Diabetes, Asthma.

Is the remote patient management software compliant?

The software is FHIR/FL7 compliant which means it can integrate with a wide range of systems. Clinitouch is DTAC-compliant, so you can have full confidence we meet the highest standards for clinical safety, data protection, security, usability and accessibility standards.

The software is accredited by Cyber Essentials Plus and DSPT certificates.

Clinitouch is hosted via Microsoft Azure which is ISO27001 accredited.

Clinitouch is at the forefront of interoperability discussions at a national scale.

Can I adjust the platform and programme to suit my brand?

Clinitouch is fully customizable so can be used to deploy remote patient monitoring for any condition or specific needs. You can choose from a library of built in pathways or as a result of our strategic partnership with Clinitouch we can design a programme to suit your brand.

What are the benefits of using the platform?

Optimal adherence, stable patients and innovation in patient care with remote monitoring.

How does the platform work?

We are happy to set up a demo but there are 3 areas – a patient app, a Clinitouch platform designed for your brand and a Clinical reporting dashboard.

Why Clinitouch and not one of the other platforms available?

Clinitouch has been deployed at scale in the NHS for over 10 years with published, proven results, including one of the biggest hospital at home rollouts in England supporting millions of patients over 16 clinical pathways. Clinitouch has also won multiple awards for NHS collaborations.

Still have a question?

Get in touch and we would love to tell you more.

Contact
Share by: